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Summary
Background: The maintenance of the body’s Mg2+ balance is
of great importance because of its involvement in numerous
enzymatic systems and its intervention in neuromuscular
excitability, protein synthesis, and nucleic acid stability.
Recently, the transient receptor potential melastatin 6
(TRPM6) was identified as the gatekeeper of active Mg2+ trans-
port and therefore plays a crucial role in the regulation of Mg2+
homeostasis. Remarkably, TRPM6 combines a Mg2+ channel
with an a-kinase domain whose function remains elusive.
Results:Here, we identify the receptor for activated C-kinase 1
(RACK1) as the first regulatory protein of TRPM6 that associ-
ates with the a-kinase domain. RACK1 and TRPM6 are both
present in renal Mg2+-transporting distal convoluted tubules.
We demonstrate that RACK1 inhibits channel activity in an
a-kinase activity-dependent manner, whereas small interfer-
ence (si) RNA-mediated knockdown of RACK1 increases the
current. Moreover, threonine1851 in the a-kinase domain was
identified as an autophosphorylation site of which the phos-
phorylation state is essential for the inhibitory effect of
RACK1. Importantly, threonine1851 was crucial for the Mg2+
sensitivity of TRPM6 autophosphorylation and channel
activity. TRPM6 channel activity was less sensitive to Mg2+
when RACK1 was knocked down by siRNA. Finally, activation
of protein kinase C by phorbol 12-myristate 13-acetate-PMA
prohibited the inhibitory effect of RACK1 on TRPM6 channel
activity.
Conclusions: We propose a unique mode of TRPM6 regula-
tion in which the Mg2+ influx is controlled by RACK1 through
its interaction with the a-kinase and the phosphorylation state
of the threonine1851 residue.
Introduction
The maintenance of the body’s Mg2+ balance is of crucial
importance for various vital cellular processes [1, 2]. Mg2+
homeostasis in mammals depends on the equilibrium between
intestinal absorption and renal excretion. The renal distal
convoluted tubule (DCT) reabsorbs w10% of the filtered
Mg2+, and the reabsorption rate in this segment defines the
final urinary Mg2+ concentration [3]. Mg2+ reabsorption in
*Correspondence: j.hoenderop@ncmls.ru.nl
3These authors contributed equally to this work.DCT is active and transcellular in nature, but the molecular
details and regulation of this pathway remain largely unknown.
Recently, transient receptor potential melastatin 6 (TRPM6)
was identified as a pivotal component in active Mg2+ (re)ab-
sorption, mutations of which cause hypomagnesemia with
secondary hypocalcemia (HSH) [4, 5]. TRPM6 is localized along
the apical membrane of DCT and intestinal cells. It confines
a Mg2+-permeable channel, the activity of which is strongly
regulated by the intracellular Mg2+ concentration ([Mg2+]i) [2].
Expression of TRPM6 is regulated by dietary Mg2+, whereas
TRPM7 is unaffected, supporting the idea of an important
role of TRPM6 in transepithelial Mg2+ transport [6].
Remarkably, TRPM6 and TRPM7 contain a unique carboxyl
(C)-terminal serine/threonine protein kinase domain belonging
to the a-kinase family [7–9]. This distinctive combination of
a channel and an enzyme domain within a single molecule
raises still unsolved questions concerning the regulatory role
of this catalytic domain on channel activity. While it has been
demonstrated that the TRPM7 a-kinase is able to autophos-
phorylate the channel and downstream substrates such as
myosin IIA heavy chain and annexin I [10–13], the role of this
a-kinase activity in modulating channel function is far from
clear. Previous studies indicated that the a-kinase activity is
not essential for TRPM7 activation [11, 13] and that regulation
of TRPM7 activity by intracellular Mg2+ is dissociated from
autophosphorylation or a-kinase activity [13]. Other groups
demonstrated regulation of TRPM7 activity by intracellular
Mg2+ and nucleotides as well as the cAMP/protein kinase A
pathway, which required the a-kinase [14, 15]. It was reported
that deletion of the TRPM7 a-kinase domain or phosphotrans-
ferase-deficient kinase mutants results in nonfunctional
channels [7]. Compared to TRPM7, little is known about the
a-kinase function of TRPM6. So far, only one study reported
that the a-kinase of TRPM6 is capable of crossphosphoryla-
tion of TRPM7, but not vice versa, underlying the functional
nonredundancy of these two ‘‘chanzymes’’ [12].
The aim of the present study was, therefore, to investigate
the role of the a-kinase domain in TRPM6 channel activity
through the identification of regulatory proteins specifically
interacting with the a-kinase domain.
Results
RACK1 Associates with TRPM6
To identify potential TRPM6-interacting proteins, two inde-
pendent approaches were used, i.e., the yeast two-hybrid
screening of a mouse kidney cDNA library with the complete
C-tail of TRPM6 and the combination of a GST pull-down
with the a-kinase domain of TRPM6 in mouse kidney lysate
followed by Fourier transform ion cyclotron resonance mass
spectrometry (FTMS). RACK1, a scaffold protein originally
discovered as an adaptor for protein kinase C (PKC) [16],
was identified as a TRPM6 interacting protein in both
approaches. Figure 1A shows that RACK1 interacted with
TRPM6, whereas no interaction was observed in the absence
of either RACK1 or the TRPM6 C-tail. To further establish this
interaction, GST pull-down binding assays were performed,
which demonstrated that RACK1 interacts specifically with
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169the a-kinase domain, but not with GST alone (Figure 1B). Next,
the association between TRPM6 and RACK1 was substanti-
ated in mammalian HEK293 cells. RACK1 coprecipitated with
the GST-kinase and GST-TRPM6-C-tail, but not with GST-
TRPM6-C-tail-D-kinase and GST alone (Figure 1C). Further-
more, coprecipitation experiments also demonstrated that
the endogenously expressed RACK1 in HEK293 cells is asso-
ciated with the TRPM6 a-kinase domain (Figure 1D). Finally,
coimmunoprecipitation studies of RACK1 with full-length
TRPM6 or TRPM6 D-kinase in HEK293 cells showed that
wild-type TRPM6 but not TRPM6 D-kinase coprecipitates
with RACK1 (Figure 1E).
Mapping of the RACK1 Binding Site in TRPM6
To determine the RACK1 binding site within TRPM6, a series of
deletion mutants in the a-kinase domain of the channel was
constructed and evaluated for their interaction with [35S]-me-
thionine-labeled RACK1 protein using pull-down experiments
(Figure 1F). The interaction between the two proteins was
abolished when TRPM6 was truncated at position 1857,
whereas truncation at position 1885 had no effect on the inter-
action with RACK1. Moreover, a GST-fusion protein containing
only the short stretch between the amino acids 1857 and 1885
Figure 1. RACK1 Interacts with the a-Kinase
Domain in TRPM6
(A) The C terminus of TRPM6 and the empty pAS1
vector were coexpressed with full-length RACK1
into the Y153 yeast strain and grown on media
without tryptophan, leucine, and histidine.
(B) GST pull-down assay between [35S]-methio-
nine-labeled RACK1 protein and GST or GST
fused to the a-kinase domain.
(C) Coprecipitation studies of GST-kinase, GST-
TRPM6-C-tail-D-kinase, and GST-TRPM6-C-tail
in RACK1-expressing HEK293 cells (top panel).
RACK1 input (1%) expression was analyzed by
immunoblotting (bottom panel).
(D) Coprecipitation studies of GST and GST-a-
kinase with endogenous RACK1 in HEK293 cells
(top panel). RACK1 input (0.5%) expression was
analyzed by immunoblotting (bottom panel).
(E) Coimmunoprecipitation studies of RACK1
with GFP-TRPM6, GFP-TRPM6 antibody, or GFP-
TRPM6 D-kinase in HEK293 cells (top panel).
Input (0.5%) expression was analyzed by immu-
noblotting (bottom panel).
(F) Mapping of the RACK1 binding site within the
a-kinase domain. Schematic diagram of the
GST-fusion proteins containing different trunca-
tions of the a-kinase.
(G) Coomassie staining of the SDS/PAGE gel.
(H) RACK1 binding site in the predicted 3D struc-
ture model of the a-kinase domain.
of the TRPM6-kinase domain bound
to RACK1 (Figure 1F). Therefore, the
RACK1 binding site within TRPM6 is
restricted to the region between the po-
sitions 1857 and 1885. The integrity and
quantity of the GST-fusion proteins was
analyzed and confirmed by Coomassie
staining (Figure 1G). To explore the
RACK1 binding site in the TRPM6 a-ki-
nase domain, the tertiary structure of
TRPM6 a-kinase domain was modeled
by SWISS-MODEL (http://swissmodel.expasy.org//
SWISS-MODEL.html) (Figure 1H), based on the homology be-
tween the TRPM6 a-kinase and the crystallized TRPM7 a-ki-
nase domain [17]. Due to the high homology between the
TRPM7 and TRPM6 a-kinase domains (84%), these two a-ki-
nases share a highly conserved secondary structure. Indeed,
the GST pull-down assay showed that RACK1 also interacts
with the TRPM7 a-kinase domain (see Figure S1A available on-
line). The surface and accessibility analysis of the RACK1 bind-
ing site (6th, 7th, and 8th b sheets) suggested that, among the
28 amino acids of the RACK1 binding site, 18 are localized at
the surface of the TRPM6 a-kinase domain (see http://www.
cmbi.ru.nl/whvensela/trpm6/).
RACK1 and TRPM6 Coexpress in Kidney
To study the localization of RACK1 in kidney, immunohis-
tochemistry was performed on kidney sections using the
thiazide-sensitive Na+/Cl2 cotransporter (NCC) as a DCT
marker. These analyses indicated immunopositive staining
for RACK1 in the NCC-expressing DCT cells (Figure 2A, top
panel). TRPM6 completely colocalized with NCC [2] along
the apical membrane in DCT, indicating the presence of
RACK1 in the TRPM6-expressing DCT segment (Figure 2A,
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confirmed the colocalization of RACK1 and TRPM6 in the
DCT (Figure 2B).
Figure 2. Localization of RACK1 in Kidney
(A) Immunohistochemical analysis of RACK1
(green) and NCC (red) in kidney sections (top
panel). Kidney sections were costained with anti-
bodies against TRPM6 (green) and NCC (red).
(B) Immunohistochemical analysis of TRPM6
(red) and RACK1 (green) in rat kidney sections.
Small Interference RNA-Mediated
RACK1 Silencing Stimulates
TRPM6 Activity
To further elucidate the molecular mech-
anism of the RACK1 inhibitory effect,
siRNA technology was applied. Immu-
noblot analysis revealed a significant
downregulation of RACK1 protein abun-
dance in HEK293 cells expressing
RACK1-targeted siRNA(1) and siRNA(2)
in comparison to mock-transfected cells
(Figures 3F and 3G). siRNA(1) and
siRNA(2) forRACK1 induced a significant
increase of the TRPM6 current ampli-
tude [356 6 31 pA/pF, 218 6 1 pA/pF
and 397 6 25 pA/pF, 233 6 6 pA/pF
for RACK1 siRNA(1) and siRNA(2) at
+80 and 280 mV, respectively, in com-
parison to 275 6 26 pA/pF, 213 6
2 pA/pF for TRPM6 and empty vector,
respectively] (Figure 3H and Figures
S2C and S2D). The siRNA for luciferase,
siRNA(luc), did not significantly affect
TRPM6 current amplitudes. Importantly,
RACK1 siRNA(1),RACK1 siRNA(2), and siRNA(luc) did not alter
the current amplitude of the TRPM6D-kinase mutant (Figure 3I
and Figures S2E and S2F).RACK1 Inhibits TRPM6 Channel Activity
The functional role of RACK1 on TRPM6 current was investi-
gated in HEK293 cells by whole-cell recordings. In mock-
transfected HEK293 cells, dialyzed with a Mg2+-free pipette
solution, around 40% of the cells developed small albeit signif-
icant currents, generally referred to as the Mg2+-inhibited
cation current (MIC current) [18, 19]. This endogenous current
was approximately ten times smaller and developed over a lon-
ger time period compared to the TRPM6 current (Figure S1D).
We demonstrated that coexpression of RACK1 with TRPM6
significantly inhibited the TRPM6-mediated current amplitude
in a dose-dependent manner. TRPM6 current was reduced by
56% 6 4% and 88% 6 3% compared to TRPM6 alone when
0.1 mg or 0.5 mg RACK1 cDNA, respectively, was cotransfected
(Figures 3A–3C and Figure S2A). Furthermore, RACK1 also
inhibited the TRPM7 channel activity (Figures S1B and S1C).
However, the inhibitory effect of RACK1 on TRPM6/7 current
was specific, since RACK1 did not significantly affect the
current in TRPV5-expressing HEK293 cells (211% 6 3%,
216% 6 3%, and 29% 6 2% at 280 mV in divalent-free,
EDTA, and 10 mM Ca2+ solutions, respectively, n = 10–12 cells
as described previously [20]). Importantly, RACK1 coexpres-
sion with an a-kinase-deleted TRPM6 mutant (TRPM6
D-kinase) failed to suppress the TRPM6 D-kinase-mediated
current at both +80 and 280 mV (Figures 3D and 3E and
Figure S2B).RACK1-Mediated Inhibition of TRPM6 Is Kinase
Activity Dependent
Next, the role of the kinase-mediated autophosphorylation
was investigated. TRPM6 a-kinase autophosphorylation activ-
ity was first assessed by an in vitro protein kinase assay.
Figure 4A indicates that TRPM6 is autophosphorylated,
whereas deletion of its a-kinase or the addition of alkaline
phosphatase prevents channel autophosphorylation. Next,
we constructed a phosphotransferase-deficient mutant
(K1804R) according to the homologous TRPM7 phosphotrans-
ferase-deficient mutant (K1648R) [11]. The in vitro phosphoryla-
tion assay showed that the kinase activity of the K1804R mutant
was abolished, while the mutant was equally expressed
compared to wild-type TRPM6 (Figure 4B). K1804R mutant
was still able to bind RACK1, as demonstrated by GST pull-
down assay (Figure S3A). K1804R mutant displayed current
amplitude and current development similar to the wild-type
channel. Importantly, RACK1 was unable to inhibit the K1804R
mutant-mediated current (Figure 4C and Figures S3B and
S3C).
Autophosphorylation of Threonine1851 in the Kinase
Domain Is Essential for the Inhibitory Effect of RACK1
To address the autophosphorylation site(s) in TRPM6 that are
essential for the regulatory effect of RACK1, the purified
GST-TRPM6 a-kinase protein was subjected to an in vitro
phosphorylation assay and subsequently analyzed by FTMS.
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(A) Time course of the current density (pA/pF) at +80 mV of TRPM6 (B), TRPM6 and RACK1 (0.5 mg,A), TRPM6 and RACK1 (0.1 mg,:), and mock TRPM6 (*)
transfected HEK293 cells.
(B) Corresponding time course at 280 mV.
(C) Averaged values of the current density at +80 and280 mV after 200 s of mock TRPM6 (n = 10), TRPM6 (n = 22), mock TRPM6 and RACK1 (0.1 mg, n = 11),
TRPM6 and RACK1 (0.1 mg, n = 18), mock TRPM6 and RACK1 (0.5 mg, n = 13), and TRPM6 and RACK1 (0.5 mg, n = 24). Open bars correspond to cells
transfected with mock-transfected DNA, and closed bars to cells transfected with TRPM6 in the absence and presence of RACK1. *p = 0.001 compared
to TRPM6 current.
(D) Time course of the current density at +80 mV of TRPM6 D-kinase (,) and TRPM6 D-kinase and RACK1 (0.5 mg,-) transfected HEK293 cells.
(E) Averaged values of the current density at +80 and280 mV after 200 s of mock TRPM6 D-kinase (n = 9), TRPM6 D-kinase (n = 22), mock TRPM6 D-kinase
and RACK1 (0.5 mg, n = 10), and TRPM6D-kinase and RACK1 (0.5 mg, n = 19) transfected HEK293 cells. Open and closed bars correspond to cells transfected
with mock TRPM6 D-kinase and TRPM6 D-kinase, respectively, in the absence and presence of RACK1.
(F and G) Immunoblot analysis of RACK1 and b-actin expression in mock, siRNA-RACK1(1), and siRNA-RACK1(2) transfected HEK293 cells.
(H) Averaged values of the current density at +80 and280 mV after 200 s of mock TRPM6 (n = 9), TRPM6 (n = 19), mock TRPM6 and siRNA-RACK1(1) (0.5 mg,
n = 17), TRPM6 and siRNA-RACK1(1) (0.5 mg, n = 21, p = 0.029), mock TRPM6 and siRNA-RACK1(2) (0.1 mg, n = 18), TRPM6 and siRNA-RACK1(2) (0.1 mg,
n = 23, p = 0.001), mock TRPM6 and siRNA(luc) (0.5 mg, n = 13), and TRPM6 and siRNA(luc) (0.5 mg, n = 17, p = 1.000). *p < 0.05 compared to the TRPM6
current. Open bars correspond to cells that are transfected with mock DNA, whereas closed bars to cells transfected with TRPM6 in the absence and pres-
ence of siRNA-RACK1 or luciferase.
(I) Similarly to Figure 3H, averaged values of mock TRPM6 D-kinase (n = 10), TRPM6 D-kinase (n = 23), mock TRPM6 D-kinase and siRNA-RACK1(1) (0.5 mg,
n = 12), TRPM6 D-kinase and siRNA-RACK1(1) (0.5 mg, n = 19, p = 1.000), mock TRPM6 D-kinase and siRNA-RACK1(2) (0.1 mg, n = 17), TRPM6 D-kinase and
siRNA-RACK1(2) (0.1 mg, n = 22, p = 1.000), mock TRPM6 D-kinase and siRNA(luc) (0.5 mg, n = 18), and TRPM6 D-kinase and siRNA(luc) (0.5 mg, n = 25,
p = 1.000) current densities. p values are relative to the TRPM6 D-kinase current.
Values are expressed as mean 6 SEM.Figure 5A revealed a single autophosphorylation site within the
a-kinase domain corresponding to the threonine residue at
position 1851 (T1851). Interestingly, in the tertiary structure
model of the TRPM6 a-kinase domain, T1851 is located at the
end of the fourth a helix adjacent to the RACK1 binding site
(Figure 5B). Subsequently, T1851 was either point mutated
into an alanine, resulting in a nonphosphorylated residue
(T1851A), or into an aspartate, mimicking the constitutive
autophosphorylated threonine residue (T1851D). Both T1851A
and T1851D mutations significantly decreased TRPM6 auto-
phosphorylation in comparison to the wild-type channel(Figure 5C and Figure S4A), while GST pull-down assays
demonstrated that RACK1 binding to T1851A and T1851D
mutants was not altered (Figure S4B). Importantly, the expres-
sion of the (mutated) TRPM6 proteins was equal (Figure 5C,
lower panel). Furthermore, both mutants (T1851A and T1851D)
displayed currents similar to the wild-type channel (Figures
5D and 5E and Figures S4C–S4F). However, the T1851A muta-
tion prevented the inhibitory effect of RACK1 (Figure 5D and
Figures S4C and S4D), whereas the RACK1-induced inhibition
remained unaltered when coexpressed with the T1851D mutant
(Figure 5E and Figures S4E and S4F).
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in Mg2+-Dependent Channel Activity
To explore whether RACK1 and the T1851 residue in thea-kinase
domain are important for the inhibitory effect of Mg2+ on TRPM6
current, the influence of [Mg2+] on TRPM6 and T1851A mutant
autophosphorylation was investigated. TRPM6 autophosphor-
ylation activity was strongly dependent on the Mg2+ concentra-
tion and steadily increased in the physiological range of 0.1–1.0
mM Mg2+ (Figure 5F). In contrast, the autophosphorylation
activity of the T1851A mutant was not affected by the Mg2+ con-
centration (Figure 5G). Both TRPM6 and T1851A mutant channel
activities were significantly inhibited by Mg2+ in the patch-
pipette. However, the T1851A mutant channel was less sensitive
to the intracellular Mg2+ concentration compared to wild-type
TRPM6 (IC50 0.72 6 0.07 mM versus IC50 0.51 6 0.06 mM,
Figure 4. Inhibition of TRPM6 by RACK1 Depends on Phosphorylation of
the a-Kinase
(A) In vitro protein kinase assay of TRPM6 and the TRPM6 D-kinase mutant
(32P, top panel). Addition of alkaline phosphatase (AP) was used as a nega-
tive control. Immunoblotting (IB, bottom panel) and densitometry quantifi-
cation (right panel) of TRPM6 and TRPM6 D-kinase expression. *p =
0.001, n = 3.
(B) In vitro protein kinase assay of TRPM6 and the K1804R mutant (32P, top
panel). Immunoblotting (IB, bottom panel) and densitometry quantification
(right panel) of TRPM6 and K1804R expression. *p = 0.001, n = 3.
(C) Summary of the current density at +80 and 280 mV of K1804R (n = 22),
K1804R and RACK1 (0.5 mg, n = 24; p = 1.000 compared to the K1804R current),
mock K1804R (n = 15), and mock K1804R and RACK1 (n = 16). Open bars
correspond to mock conditions, whereas closed bars to cells transfected
with K1804R in the absence and presence of RACK1.
Values are expressed as mean 6 SEM.respectively) (Figure 5H). Figure 5I showed that knockdown of
endogenous RACK1 by siRNA significantly reduces the Mg2+-
dependent inhibition of the TRPM6 current. Together, these
data suggest that the T1851 phosphorylation-dependent inhibi-
tory effect of RACK1 may play an important role in the suppres-
sion of the TRPM6 current by intracellular free Mg2+.
Coexpression of RACK1 Does Not Affect Expression
of TRPM6 at the Plasma Membrane
The influence of RACK1 on the amount of TRPM6 channels
expressed at the plasma membrane was investigated by
cell-surface biotinylation experiments. As shown in Figure 6
(upper panel), coexpression of RACK1 did not affect the
amount of TRPM6 channels expressed at the plasma mem-
brane. Of note, TRPM6 was equally expressed in all tested
conditions, as determined in the total cell lysates (Figure 6,
bottom panel).
RACK1 Inhibits TRPM6 in a PKC-Dependent Manner
Next, the effect of PKC activation by phorbol 12-myristate
13-acetate-PMA (PMA) [21] on the regulatory effect of
RACK1 was studied. PKC activation by preincubation with
100 nM PMA for 5 min prevented the inhibitory effect of
RACK1 on the TRPM6 current (Figure 7B and Figures S5C
and S5D). The current amplitude in the presence of PMA
was, however, not modified in cells expressing TRPM6 only
(Figure 7A and Figures S5A and S5B). To confirm the specific-
ity of PMA, HEK293 cells coexpressing TRPM6 and RACK1
were incubated with 5 mM chelerythrine chloride, a specific
PKC inhibitor [22], for 20 min prior to PMA treatment. As shown
in Figure 7B and Figures S5C and S5D, the stimulatory action
of PMA was counteracted by chelerythrine chloride, suggest-
ing that the PMA effect is indeed due to PKC activation. To
further elucidate the PKC effect, the TRPM6 C-tail was
coexpressed with RACK1 in HEK293 cells, subjected to PKC
activation by PMA or vehicle, and subsequently precipitated
using glutathione Sepharose 4B beads. The interaction of
RACK1 with the TRPM6 C-tail was significantly reduced
when PKC was activated (Figure 7C, upper panel). Importantly,
RACK1 was equally expressed in all situations (Figure 7C,
lower panel).
Discussion
In the present study, we identified RACK1 as the first TRPM6-
associated protein and demonstrated that RACK1 inhibits
TRPM6 channel activity depending on the phosphorylation
state T1851 in the a-kinase domain. First, RACK1 binds to the
TRPM6 a-kinase domain and shares a similar expression
pattern with TRPM6 in the kidney. Second, overexpression
of RACK1 inhibits TRPM6 activity, and conversely, silencing
of RACK1 by siRNA increases the TRPM6 current. Third, the
RACK1-mediated inhibition of TRPM6 is prevented by deletion
of the a-kinase domain. Fourth, inactivation of the a-kinase
abrogates the inhibitory effect of RACK1. Fifth, T1851 is identi-
fied as an important autophosphorylation site in TRPM6-
modulating channel activity by RACK1. Sixth, T1851 was crucial
for the Mg2+ sensitivity of TRPM6 autophosphorylation and
channel activity. Finally, knockdown of endogenous RACK1
by siRNA significantly reduces the Mg2+-dependent inhibition
of the TRPM6 current.
TRPM6 forms the Mg2+ influx channel involved in intestinal
and renal Mg2+ (re)absorption and is so far the only known
molecular identity in the process of active transepithelial
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(A) Analysis of phosphorylated tryptic peptide by LTQ-FT ICR mass spectrometer. For detailed information, see Experimental Procedures.
(B) Autophosphorylated threonine at position 1851 in the putative 3D structure of the TRPM6 a-kinase domain, in which the RACK1 binding site is
highlighted.
(C) In vitro protein kinase assay (32P, top panel) and immunoblotting analysis (IB, bottom panel) of TRPM6, T1851A, and T1851D mutants.
(D and E) Averaged values of the current density at +80 and280 mV of T1851A with (n = 23; p = 1.000 compared to T1851A) or without RACK1 (n = 25) (D) and
T1851D with (n = 27; p = 0.001 compared to T1851D) or without RACK1 (n = 23) (E). Open and closed bars correspond to cells transfected with mock DNA and
TRPM6 mutants, respectively, in the absence or presence of RACK1.
(F and G) In vitro phosphorylation of TRPM6 (F) and TRPM6 T1851A (G) at different Mg2+ concentrations (32P, top panels). Autoradiograms were exposed
4 days for TRPM6 and 8 days for TRPM6 T1851A. TRPM6 and TRPM6 T1851A expression was determined by immunoblotting (IB, bottom panels). The
phosphorylated proteins were quantified and plotted against 0.1 mM [Mg2+] (n = 3 for each; P 0.2 mM [Mg2+] = 0.120; P 0.5 mM [Mg2+] = 0.042; P 1.0 mM [Mg2+] =
0.049 for TRPM6 and P 0.2 mM [Mg2+] = 0.442; P 0.5 mM [Mg2+] = 0.370; P 1.0 mM [Mg2+] = 0.973 for TRPM6 T1851A).
(H) Effect of the pipette Mg2+ concentration on the inhibition of the inward Na+ current at280 mV of TRPM6 (C, n = 8–11) and the T1851A-transfected HEK293
cells (B, n = 9–13). *p < 0.05, compared to TRPM6 current in 0 mM [Mg2+].
(I) Effect of the pipette Mg2+ concentration on the inhibition of the inward Na+ current at280 mV of TRPM6 (n = 10) and TRPM6 and siRNA-RACK1(1) (0.5 mg,
n = 10, p = 0.03) transfected HEK293 cells.
Values are expressed as mean 6 SEM.Mg2+ transport. However, TRPM6 regulation remains poorly
understood. In this respect, the identification of RACK1 as
a TRPM6 regulator provides the first molecular insight into
the control of renal Mg2+ entry and, therefore, into the mainte-
nance of Mg2+ balance. The interaction between RACK1 and
TRPM6 was confirmed by GST pull-down assay and coimmu-
noprecipitation. Unfortunately, similar studies investigating an
interaction between endogenous TRPM6 and RACK1 in kidney
DCT cells were unsuccessful, possibly due to the low protein
abundance of the channel. In addition, we demonstrated that
endogenously expressed RACK1 in HEK293 cells interacts
with the TRPM6 a-kinase domain. At the molecular level, our
results suggest that RACK1 specifically binds to the 6th, 7th,
and 8th b sheets of the a-kinase domain. Eighteen amino acids
of the RACK1 binding site are located on the peripheral region
of the tertiary structure of the TRPM6 a-kinase domain, which
may facilitate the association between RACK1 and TRPM6.Importantly, we showed that RACK1 is abundantly present in
TRPM6-expressing tubules, which further suggests the
physiological relevance of the interaction between these
proteins in the kidney.
RACK1, a member of the WD-40 family of proteins, is
regarded as a scaffolding protein in multiple intracellular signal
transduction pathways, including ion channel proteins such
as the IP3 receptor, NMDA receptor, and GABAA receptor
channels [23–25]. RACK1-mediated decline of the TRPM6
current was dose dependent, and depletion of endogenously
expressed RACK1 in HEK293 cells resulted in increased
TRPM6 currents. The inhibitory effect of RACK1 requires the
a-kinase domain with functional phosphotransferase activity.
This was supported by the analysis of the TRPM6 D-kinase
and the phosphotransferase-deficient (K1804R) mutants, which
were both insensitive to RACK1. While the autophosphoryla-
tion activity of the a-kinase domain has been well documented
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activity remains elusive. Previously, it has been demonstrated
that the balance between phosphorylation and dephosphory-
lation operates as a key mechanism to regulate ion channel
activity [26, 27]. However, the phosphotransferase-deficient
K1804R mutant displayed currents indistinguishable from
wild-type TRPM6. Interestingly, the mutants T1851A and T1851D
displayed currents similar to the wild-type channel but ex-
hibited a significant albeit reduced autophosphorylation, while
the autophosphorylation of mutant K1804R was fully abolished.
These data suggest that, besides T1851, additional autophos-
phorylation sites are present in TRPM6. Our findings support
Figure 6. Coexpression of RACK1 Does Not Affect the Plasma Membrane
Expression of TRPM6
TRPM6 and RACK1-transfected HEK293 cells were subjected to cell-
surface biotinylation analysis. TRPM6 expression was analyzed by immuno-
blotting for the plasma membrane fraction (top panel) and in total cell
lysates (bottom panel). As negative control, mock cells were used.the conclusion that TRPM6 a-kinase autophosphorylation
events are not vital for TRPM6 channel activation. Consis-
tently, previous studies showed that TRPM7 phosphotransfer-
ase activity is not essential for channel activation [12, 13]. In
contrast, the inhibitory action of RACK1 requires functional
phosphotransferase activity. This notion is supported by the
fact that the current of the phosphorylation-impaired mutants
(K1804R and T1851A) is insensitive to RACK1. Furthermore, the
constitutive phosphorylated mutant T1851D was still inhibited
by RACK1. Based on these observations, an increased chan-
nel activity for the phosphorylation-impaired mutants (K1804R
and T1851A) and the TRPM6 D-kinase mutant was expected.
However, functional analysis of these mutated channel pro-
teins did not indicate elevated channel activity. It has been
demonstrated that the a-kinase domain can regulate TRPM7
channel activity via other signaling pathways besides
RACK1. For instance, previous studies [11, 14, 15] indicated
that the TRPM7 activity controlled by intracellular Mg2+, nucle-
otides, and the cAMP/protein kinase A pathway requires the
a-kinase domain or kinase activity. Therefore, it is conceivable
that removing the a-kinase domain or suppressing its phos-
photransferase activity may abolish associated regulation(s)
of TRPM6 channel activity. This could compensate a potential
upregulation of TRPM6 activity caused by removal of the inhib-
itory RACK1 action. In reminiscence of the adjacent location of
the autophosphorylation site in the a-kinase and the RACK1
binding site, we hypothesize that the phosphorylation state
of T1851 plays a key role in controlling channel activity via
RACK1. Together, our results convincingly demonstrate a
novel indirect model of regulation in which RACK1 functions
as a mediator linking autophosphorylation of the a-kinase do-
main to channel activity. In this way, TRPM6 channel activity is
controlled efficiently to manage constitutively active epithelial
Mg2+ channels. Furthermore, cell-surface biotinylation experi-
ments demonstrated that coexpression of RACK1 does not af-
fect the amount of TRPM6 channels expressed at the plasma
membrane. These data suggest that the inhibitory effect of
RACK1 on TRPM6 is likely due to channel gating. Association
of RACK1 and TRPM6 seems a dynamic process that can beFigure 7. The Inhibitory Effect of RACK1 Is PKC Dependent
(A) Effect of PKC activation by PMA (100 nM, 5 min pretreatment) on the current density at +80 and280 mV of mock TRPM6 (n = 14) and TRPM6 (n = 22). Open
bars correspond to cells transfected with mock DNA, whereas closed bars to cells transfected with TRPM6.
(B) Effect of PKC activation by PMA and PKC inhibition by chelerythrine chloride (CC, 5 mM, 20 min pretreatment prior to PMA treatment) on the current
density at +80 and280 mV of TRPM6 and RACK1 (0.5 mg, n = 7–12) transfected HEK293 cells. *p = 0.01 compared to TRPM6 and RACK1 without pretreat-
ment, and #p = 0.02 compared to TRPM6 and RACK1 pretreated with PMA.
(C) Effect of PKC activation on RACK1 binding. After PMA or vehicle preincubation, RACK1 was coprecipitated with GST-fused C-tail, separated by SDS/
PAGE, and visualized using the anti-RACK1 antibody (top panel). Immunoblotting (bottom panel) and densitometry quantification (right panel) of TRPM6-
C-tail and RACK1 binding. *p = 0.001 compared to TRPM6-C-tail.
Values are expressed as mean 6 SEM.
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effect of RACK1. An increased TRPM6 current upon PMA
treatment in TRPM6-overexpressed HEK293 cells was antici-
pated, since PKC activation prevents the RACK1 inhibitory ef-
fect in TRPM6 and RACK1-overexpressing HEK293 cells.
However, this inhibitory effect was not observed, which might
be due to the fact that the amount of endogenous RACK1 is in-
sufficient to inhibit the overexpressed TRPM6.
TRPM6 and TRPM7 confine a Mg2+-permeable channel of
which the activity is strongly regulated by [Mg2+]i [2, 7, 13,
14, 28]. Channel inactivation by elevated [Mg2+]i may function
as negative-feedback machinery to balance the Mg2+ homeo-
stasis. Matsushita and coworkers postulated that regulation of
TRPM7 channel activity by [Mg2+]i is disassociated from its
a-kinase activity [13], whereas other studies suggested the
involvement of the a-kinase domain [11, 14]. In our study, the
T1851A mutant is less sensitive to [Mg2+]i, which is in agreement
with previous studies showing that TRPM7 phosphotransfer-
ase activity influences the Mg2+-dependent inhibition of
channel activity [11, 14]. This shift in Mg2+ sensitivity could
have significant impact on TRPM6 activity during transepithe-
lial Mg2+ transport because the channel is tightly controlled by
[Mg2+]i [2]. The T
1851A mutant is still inhibited by high [Mg2+]i,
suggesting that additional Mg2+-sensing site(s) are present
within TRPM6. Our data indicated that wild-type TRPM6
autophosphorylation activity is gradually enhanced by in-
creasing the Mg2+ concentration, in contrast to autophosphor-
ylation of the T1851A mutant for which the Mg2+ sensitivity is
abolished. Thus, residue T1851 seems crucial in the Mg2+ sen-
sitivity of TRPM6 autophosphorylation. In line with our study,
Minagawa and coworkers demonstrated that the Mg2+ sensi-
tivity of PhoQ phosphorylation, vital for Escherichia coli Mg2+
homeostasis, relies on a single residue, D179 [29]. Over the
last decade, the idea was that the free [Mg2+]i is more or less
constant. However, more recent studies provided evidence
that the free [Mg2+]i concentration varies significantly [30,
31]. Enzymes like adenylate kinases and TRPM7 kinase are de-
pendent on the [Mg2+]i [11, 32, 33]. Moreover, we showed that
siRNA-mediated downregulation of endogenous RACK1 sig-
nificantly reduced the inhibition of the TRPM6 current by
Mg2+. These findings suggest that RACK1 is involved in the
Mg2+ sensitivity of TRPM6 channel activity. Together, we sug-
gest that TRPM6-mediated Mg2+ influx induces phosphoryla-
tion of T1851 located in the a-kinase domain. Subsequently,
the phosphorylation of T1851 will activate the inhibitory effect
of RACK1. This latter step may act as an intracellular feedback
regulation to control TRPM6-mediated Mg2+ influx and avoid
Mg2+ overload during renal epithelial Mg2+ transport. Our
data contribute to a further understanding of molecular mech-
anisms involved in renal Mg2+ handling and to the a-kinase-
dependent regulation of TRPM6 channel activity.
Experimental Procedures
Cell Culture and Transfection
HEK293 cells were grown and transfected as described previously [34].
DNA Constructs and cRNA Synthesis
Information about the TRPM6 and RACK1 constructs used is available
on-line.
Yeast Two-Hybrid System
Yeast two-hybrid experiments were performed as previously described [35].GST-Fusion Proteins and Pull-Down Assay
TRPM6 a-kinase GST fusion protein was purified as previously described
[35]. Please see Supplemental Data for detailed information.
Electrophysiology
Whole-cell recordings with standard pipette and extracellular solutions
were performed as already described [34]. The information on pipette
solutions used for the intracellular Mg2+ experiments is available online.
Coprecipitation, Coimmunoprecipitation, and Immunoblotting
The supernatants of cell lysates were incubated overnight with glutathione
Sepharose 4B beads at 4C. The anti-RACK1 antibody (IgM) was labeled
with biotin and precipitated by neutravidin-agarose beads (Pierce) and
then incubated overnight with the supernatants of the lysates. After exten-
sive washing with lysis buffer, the bound proteins were eluted and subjected
to SDS-PAGE followed by western blotting analysis. The immunoblotting
experiments were performed as previously described [35]. Please see
Supplemental Data for detailed information.
In Vitro Phosphorylation and Phosphatase Assays
The precipitated TRPM6 was incubated in kinase reaction buffer and 2 mCi
of [g32P]ATP for 30 min at 30C. For the in vitro phosphatase assay, 15 units
alkaline phosphatase (Roche, Mannheim, Germany) were added to TRPM6
immunoprecipitates before in vitro phosphorylation assays. The reaction
was terminated by three washing steps with phosphorylation washing
buffer. Phosphorylation was analyzed after gel electrophoresis by autoradi-
ography. Please see Supplemental Data for detailed information.
Statistical Analysis
Please see Supplemental Data for detailed information.
Supplemental Data
Additional information about the Experimental Procedures and five figures,
can be found online at http://www.current-biology.com/cgi/content/full/
18/3/168/DC1/.
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